YU72194A - Injekcione suspenzije sa produženim dejstvom i postupak za proizvodnju istih - Google Patents

Injekcione suspenzije sa produženim dejstvom i postupak za proizvodnju istih

Info

Publication number
YU72194A
YU72194A YU72194A YU72194A YU72194A YU 72194 A YU72194 A YU 72194A YU 72194 A YU72194 A YU 72194A YU 72194 A YU72194 A YU 72194A YU 72194 A YU72194 A YU 72194A
Authority
YU
Yugoslavia
Prior art keywords
suspension
procedure
production
same
continuous
Prior art date
Application number
YU72194A
Other languages
English (en)
Inventor
J. Engel
K. Klokkers-Bethke
T. Reissmann
P. Hilgard
Original Assignee
Zentaris Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh. filed Critical Zentaris Gmbh.
Priority claimed from US08/661,017 external-priority patent/US5773032A/en
Publication of YU72194A publication Critical patent/YU72194A/sh
Publication of RS49511B publication Critical patent/RS49511B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A61K38/105—Bombesin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Pronalazak se osnosi na injekcione suspenzije sa produženim dejstvom, koje sadrže terapeutski aktivne peptide kao fiziološki prihvatljive, amorfne i kristalne soli slabe rastvorljivosti i postupak za njihovo dobijenje. U okviru toga, opisana je farmaceutska kompozicija sa odloženim otpuštsanjem aktivne supstance koja se sastoji od embonantne soli LHRH analoga, gde je veličina čestica soli negde između 5 - 20 mm, gde LHRH analog može da bude cetroreliks, antrareliks, ganireliks, antid ili A - 75998 gde se pomenuta kompozicija nalazi u obliku injekcionih suspenzija sa odloženim oslobađanjem i što ne obuhvata biodegradabilne polimere ili masti.
YU72194A 1993-12-09 1994-12-08 Injekcione suspenzije sa produženim dejstvom i postupak za proizvodnju istih RS49511B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4342092A DE4342092B4 (de) 1993-12-09 1993-12-09 Langwirkende Injektionssuspension und Verfahren zur Herstellung
US08/661,017 US5773032A (en) 1993-12-09 1996-06-10 Long-acting injection suspensions and a process for their preparation

Publications (2)

Publication Number Publication Date
YU72194A true YU72194A (sh) 1997-03-07
RS49511B RS49511B (sr) 2006-10-27

Family

ID=25931926

Country Status (27)

Country Link
EP (1) EP0732934B1 (sh)
JP (1) JPH09509145A (sh)
CN (2) CN1136916C (sh)
AT (1) ATE310530T1 (sh)
AU (1) AU677748B2 (sh)
BR (1) BR9408272A (sh)
CZ (1) CZ291025B6 (sh)
DE (1) DE4342092B4 (sh)
DK (1) DK0732934T3 (sh)
EE (1) EE03224B1 (sh)
EG (1) EG20787A (sh)
ES (1) ES2251715T3 (sh)
FI (1) FI116121B (sh)
HK (1) HK1063746A1 (sh)
HR (1) HRP940978B1 (sh)
HU (1) HU217081B (sh)
IL (1) IL111928A (sh)
LV (1) LV11596B (sh)
NO (1) NO318984B1 (sh)
NZ (1) NZ277239A (sh)
PL (1) PL186929B1 (sh)
RO (1) RO119343B1 (sh)
RS (1) RS49511B (sh)
RU (1) RU2152222C1 (sh)
SK (2) SK284980B6 (sh)
WO (1) WO1995015767A1 (sh)
ZA (1) ZA949798B (sh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
DE69434553T2 (de) * 1993-12-09 2006-08-10 Zentaris Gmbh Lang wirkende injektionssuspensionen von lhrh-analogen und ein verfahren für ihre herstellung
AU5678398A (en) * 1997-01-29 1998-08-18 Takeda Chemical Industries Ltd. Sustained-release microspheres, their production and use
DE10040700A1 (de) * 2000-08-17 2002-02-28 Asta Medica Ag Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung
AU2002221139A1 (en) * 2000-12-15 2002-06-24 Takeda Chemical Industries Ltd. Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof
TW200526267A (en) * 2001-06-29 2005-08-16 Takeda Chemical Industries Ltd Controlled release composition and method of producing the same
US7098305B2 (en) 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
EP1674082A1 (de) 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
WO2008075762A1 (en) 2006-12-18 2008-06-26 Takeda Pharmaceutical Company Limited Sustained-release composition and method for producing the same
WO2011060352A1 (en) * 2009-11-16 2011-05-19 Ipsen Pharma S.A.S. Pharmaceutical compositions of melanocortin receptor ligands
CN102504018A (zh) * 2011-10-28 2012-06-20 沈阳药科大学 可持续释放的蜂毒肽帕莫酸盐及其制剂
JP6669932B2 (ja) * 2016-03-29 2020-03-18 シャンハイ・シナジー・ファーマシューティカル・サイエンシーズ・カンパニー・リミテッド ボルチオキセチンのパモ酸塩及びその結晶形
CN108969478A (zh) * 2018-08-29 2018-12-11 江南大学 一种美金刚难溶盐缓释注射剂及其制备方法
CN110003195B (zh) * 2019-05-21 2020-05-26 湖北中医药大学 鲁拉西酮晶体及其制备方法和在注射给药系统中的应用
CN112569340A (zh) * 2020-12-31 2021-03-30 苏州素仕生物科技有限公司 一种无菌布舍瑞林注射液及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852422A (en) * 1971-06-26 1974-12-03 Serono Ist Farm Long-active gonadotropins
NZ181036A (en) * 1975-06-12 1978-12-18 A Schally Luteinising hormone releasing hormone analogues and intermediates therefor
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
FR2647677B1 (fr) * 1989-05-31 1991-09-27 Roussel Uclaf Nouvelles micro-proteines, procede de preparation et application a titre de medicaments de ces nouvelles micro-proteines
CH679207A5 (sh) * 1989-07-28 1992-01-15 Debiopharm Sa
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.

Also Published As

Publication number Publication date
DE4342092B4 (de) 2007-01-11
SK284981B6 (sk) 2006-03-02
HUT75712A (en) 1997-05-28
ES2251715T3 (es) 2006-05-01
HU217081B (hu) 1999-11-29
BR9408272A (pt) 1996-12-17
PL314913A1 (en) 1996-09-30
WO1995015767A1 (en) 1995-06-15
NO961877L (no) 1996-05-09
IL111928A (en) 1999-11-30
IL111928A0 (en) 1995-03-15
DE4342092A1 (de) 1995-06-14
FI962354A0 (fi) 1996-06-06
CN1494919A (zh) 2004-05-12
SK66796A3 (en) 1997-08-06
NO318984B1 (no) 2005-05-30
ZA949798B (en) 1995-08-18
FI116121B (fi) 2005-09-30
CZ291025B6 (cs) 2002-12-11
EP0732934A1 (en) 1996-09-25
HU9601584D0 (en) 1996-08-28
EE03224B1 (et) 1999-10-15
EP0732934B1 (en) 2005-11-23
SK284980B6 (sk) 2006-03-02
FI962354A (fi) 1996-06-06
JPH09509145A (ja) 1997-09-16
RO119343B1 (ro) 2004-08-30
CN1136779A (zh) 1996-11-27
AU1219995A (en) 1995-06-27
CN1136916C (zh) 2004-02-04
HK1063746A1 (en) 2005-01-14
NO961877D0 (no) 1996-05-09
LV11596B (en) 1997-06-20
NZ277239A (en) 1997-03-24
CZ142096A3 (en) 1996-12-11
CN1248732C (zh) 2006-04-05
AU677748B2 (en) 1997-05-01
DK0732934T3 (da) 2006-03-27
PL186929B1 (pl) 2004-04-30
EG20787A (en) 2000-02-29
HRP940978A2 (en) 1997-02-28
RS49511B (sr) 2006-10-27
HRP940978B1 (en) 2006-08-31
RU2152222C1 (ru) 2000-07-10
ATE310530T1 (de) 2005-12-15
LV11596A (lv) 1996-12-20

Similar Documents

Publication Publication Date Title
YU72194A (sh) Injekcione suspenzije sa produženim dejstvom i postupak za proizvodnju istih
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
DE69407404D1 (de) Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung
DE59310197D1 (de) Lagerstabile wässrige pharmazeutische zubereitungen von g-csf
DK0631619T3 (da) Rekonstrueret bruskvæv
SE9503143D0 (sv) New preparation
ES2161279T3 (es) Nucleosidos y nucleotidos que contienen racimos de boro.
DE69631063D1 (de) Stabilisierende formulierung für ngf
PL327200A1 (en) Endothelium cells proliferation inhibitor and methods of using same
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
TR199800954T2 (xx) Y�ksek i�erikli famsiklovir tabletleri.
MY119896A (en) Long-acting injection suspensions and a process for their preparation.
TR199701463T1 (en) Sorbin asiti i�eren hidrojel.